Originally published September 29 2005
GlaxoSmithKline pays $150 million to settle government charges
by Mike Adams, the Health Ranger, NaturalNews Editor
Charged by the government with fraudulently inflating drug prices, pharmaceutical giant GlaxoSmithKline, while admitting to no wrongdoing, has paid more than $150 million to settle the charges out of court.
GlaxoSmithKline (GSK.L: Quote, Profile, Research) has paid more than $150 million to settle government charges that the company fraudulently inflated the price of drugs purchased by federal health-care programs, the U.S. Justice Department said on Tuesday.
The settlement stems from allegations that the company violated the U.S. False Claims Act in the sale and marketing of Zofran and Kytril, two nausea drugs prescribed to patients undergoing cancer treatment, the department said.
GlaxoSmithKline issued a statement saying it did nothing wrong, but agreed to settle the case to avoid litigation.
According to the department, Glaxo engaged in a scheme to deliberately set and maintain inflated prices for the two drugs, knowing that federal health care programs used those prices to establish their reimbursement rates.
The Justice Department "will not tolerate fraudulent pricing practices designed to reap profits for drug companies and doctors at the expense of health care programs for the poor and the elderly," an official said in a statement.
Of the amount paid by GlaxoSmithKline, $26 million will go to whistle-blowers who prompted the investigation and another $10 million will go to state governments.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml